ALPS Medical Breakthroughs ETF Rating $35.05 +0.41 (+1.18%) As of 08/15/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.95Holdings in SBIO have an aggregate rating of Moderate Buy based on 289 analyst ratings issued in the past year covering 25 companies (58.3% of the portfolio).SBIO Aggregate Price Target$35.05High Prediction$35.05Average Prediction$35.05Low Prediction$35.05Holdings in SBIO have an aggregate price target of $35.05 and a range of $35.05 to $35.05 covering 25 companies (58.3% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.69%RYTMRhythm Pharmaceuticals$97.61+1.2%3.7613 of 5 stars3.07$101.57 4.1%15News CoverageInsider Trade3.37%RNAAvidity Biosciences$46.47+0.9%2.9395 of 5 stars3.06$67.00 44.2%18Insider Trade3.13%AXSMAxsome Therapeutics$109.21+0.4%4.7264 of 5 stars3.07$178.00 63.0%153.07%NUVLNuvalent$76.04-1.0%3.1663 of 5 stars3.09$119.60 57.3%112.87%MRUSMerus$67.25+0.5%2.0935 of 5 stars3.09$88.50 31.6%112.73%ALKSAlkermes$29.05+2.8%4.75 of 5 stars2.83$41.08 41.4%12News CoveragePositive News2.71%VKTXViking Therapeutics$40.03-0.5%4.083 of 5 stars3.00$86.92 117.1%14Positive NewsGap Up2.58%ACADACADIA Pharmaceuticals$25.33+3.3%3.9047 of 5 stars2.61$28.88 14.0%18Analyst Upgrade2.50%KRYSKrystal Biotech$150.270.0%4.6319 of 5 stars3.00$210.75 40.2%92.48%CYTKCytokinetics$38.67-0.1%3.5722 of 5 stars2.93$71.58 85.1%15News CoverageAnalyst Revision2.41%ACLXArcellx$74.08+3.1%1.836 of 5 stars3.13$114.31 54.3%152.34%PCVXVaxcyte$32.70+4.0%2.1255 of 5 stars3.09$136.50 317.4%112.34%ZLABZai Lab$35.73+2.3%2.4127 of 5 stars2.83$57.22 60.1%6News CoverageInsider TradeGap Up2.31%AKROAkero Therapeutics$49.38-1.4%3.9466 of 5 stars3.00$81.57 65.2%8Trending NewsEarnings ReportInsider TradeAnalyst RevisionHigh Trading Volume2.17%PTCTPTC Therapeutics$48.82+0.2%4.4557 of 5 stars2.63$70.15 43.7%162.11%MLTXMoonLake Immunotherapeutics$54.39-0.9%2.5384 of 5 stars2.78$74.43 36.8%9Analyst Revision2.04%PTGXProtagonist Therapeutics$56.07+2.0%2.0476 of 5 stars3.00$67.20 19.9%9Positive News1.96%MTSRMetsera$31.14+2.8%N/A3.00$55.00 76.6%51.93%MIRMMirum Pharmaceuticals$67.93+4.8%3.4251 of 5 stars3.13$74.13 9.1%8Insider Trade1.82%APLSApellis Pharmaceuticals$27.75+0.5%3.9916 of 5 stars2.58$34.12 22.9%19Short Interest ↑1.70%NAMSNewAmsterdam Pharma$25.07-0.4%3.6659 of 5 stars2.89$41.20 64.3%91.67%XENEXenon Pharmaceuticals$38.23+0.7%2.0404 of 5 stars3.00$53.20 39.2%11Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.61%CRNXCrinetics Pharmaceuticals$30.72+3.5%3.4556 of 5 stars2.78$68.86 124.1%9Gap Up1.49%ARWRArrowhead Pharmaceuticals$20.51+9.2%4.1962 of 5 stars3.00$43.14 110.4%9Trending NewsInsider TradeAnalyst RevisionHigh Trading Volume1.31%TARSTarsus Pharmaceuticals$54.21+0.1%1.7934 of 5 stars3.00$66.67 23.0%7News CoverageInsider Trade This page (NYSEARCA:SBIO) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access